Literature DB >> 1585291

Antibiotic treatment in pneumonia due to Q fever.

V Sobradillo1, R Zalacain, A Capelastegui, F Uresandi, J Corral.   

Abstract

BACKGROUND: Whether Q fever responds better to doxycycline or erythromycin is unknown.
METHODS: The efficacy of doxycycline and erythromycin in the treatment of pneumonia due to Q fever was assessed in a prospective, randomised, double blind study of 82 patients with a diagnosis of pneumonia and features suggestive of Q fever infection; 48 proved to have Q fever. Of the 48, 23 received doxycycline 100 mg twice a day and 25 patients received erythromycin 500 mg six hourly, both for 10 days.
RESULTS: Both treatment groups had similar demographic characteristics. Fever showed a more rapid reduction in the doxycycline group (3(1.6) days versus 4.3(2) days). Side effects were observed in two patients receiving doxycycline compared with 11 patients receiving erythromycin (p less than 0.01). No differences were observed in other clinical or radiological measures. By day 40 the chest radiograph was normal in 47 of 48 patients.
CONCLUSION: The results demonstrate the self limiting and benign nature of most cases of pneumonia due to Q fever. Doxycycline was more effective than erythromycin.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1585291      PMCID: PMC463691          DOI: 10.1136/thx.47.4.276

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


  12 in total

1.  Tetracycline in the treatment of "Q" fever.

Authors:  O W POWELL; K P KENNEDY; M McIVER; H SILVERSTONE
Journal:  Australas Ann Med       Date:  1962-08

2.  Q fever in California. III. Aureomycin in the therapy of Q fever.

Authors:  W H CLARK; E H LENNETTE; G MEIKLEJOHN
Journal:  AMA Arch Intern Med       Date:  1951-02

3.  Antibiotic studies in pneumonia. Pitfalls in interpretation and suggested soluions.

Authors:  J W Chow; V L Yu
Journal:  Chest       Date:  1989-09       Impact factor: 9.410

4.  [Calculating the number of patients necessary for designing a clinical study].

Authors:  X Carné; V Moreno; M Porta Serra; E Velilla
Journal:  Med Clin (Barc)       Date:  1989-01-21       Impact factor: 1.725

5.  The importance of Coxiella burnetii as a cause of pneumonia in Nova Scotia.

Authors:  T J Marrie; E V Haldane; R S Faulkner; C Kwan; B Grant; F Cook
Journal:  Can J Public Health       Date:  1985 Jul-Aug

6.  In vivo response of acute Q fever to erythromycin.

Authors:  M E Ellis; E M Dunbar
Journal:  Thorax       Date:  1982-11       Impact factor: 9.139

7.  Q fever treated with erythromycin.

Authors:  L J D'Angelo; R Hetherington
Journal:  Br Med J       Date:  1979-08-04

8.  Comparison of two oral forms of erythromycin in the treatment of acute respiratory tract infections. A multicentre general practice study.

Authors:  J Macklin; R Barden; S Coles
Journal:  J Int Med Res       Date:  1989 May-Jun       Impact factor: 1.671

Review 9.  Q fever: current concepts.

Authors:  L A Sawyer; D B Fishbein; J E McDade
Journal:  Rev Infect Dis       Date:  1987 Sep-Oct

10.  Etiology of community-acquired pneumonia in patients requiring hospitalization.

Authors:  E Berntsson; J Blomberg; T Lagergård; B Trollfors
Journal:  Eur J Clin Microbiol       Date:  1985-06       Impact factor: 3.267

View more
  11 in total

1.  Q fever in Quebec (1989-93): Report of 14 cases.

Authors:  M Goyette; A Poirier; J Bouchard; E Morrier
Journal:  Can J Infect Dis       Date:  1994-05

Review 2.  Community-acquired pneumonia related to intracellular pathogens.

Authors:  Catia Cillóniz; Antoni Torres; Michael Niederman; Menno van der Eerden; James Chalmers; Tobias Welte; Francesco Blasi
Journal:  Intensive Care Med       Date:  2016-06-08       Impact factor: 17.440

Review 3.  From Q Fever to Coxiella burnetii Infection: a Paradigm Change.

Authors:  Carole Eldin; Cléa Mélenotte; Oleg Mediannikov; Eric Ghigo; Matthieu Million; Sophie Edouard; Jean-Louis Mege; Max Maurin; Didier Raoult
Journal:  Clin Microbiol Rev       Date:  2017-01       Impact factor: 26.132

Review 4.  Antimicrobial therapies for Q fever.

Authors:  Gilbert J Kersh
Journal:  Expert Rev Anti Infect Ther       Date:  2013-09-27       Impact factor: 5.091

Review 5.  Q fever.

Authors:  M Maurin; D Raoult
Journal:  Clin Microbiol Rev       Date:  1999-10       Impact factor: 26.132

6.  Case Report: Metagenomic Next-Generation Sequencing Clinches the Diagnosis of Acute Q Fever and Verified by Indirect Immunofluorescence Assay.

Authors:  Yide Yang; Qingmiao Shi; Qian Jin; Zhangnv Yang; Wangfang Li; Jianfeng Han; Juanjuan Mao; Beiwen Zheng
Journal:  Front Med (Lausanne)       Date:  2022-05-26

7.  Coxiella burnetii Infection in a Community Operating a Large-Scale Cow and Goat Dairy, Missouri, 2013.

Authors:  Holly M Biggs; George Turabelidze; Drew Pratt; Suzanne R Todd; Kara Jacobs-Slifka; Naomi A Drexler; Gail McCurdy; Jennifer Lloyd; Charles L Evavold; Kelly A Fitzpatrick; Rachael A Priestley; Joseph Singleton; David Sun; Minh Tang; Cecilia Kato; Gilbert J Kersh; Alicia Anderson
Journal:  Am J Trop Med Hyg       Date:  2016-01-25       Impact factor: 2.345

8.  Etiology of community-acquired pneumonia in a population-based study: link between etiology and patients characteristics, process-of-care, clinical evolution and outcomes.

Authors:  Alberto Capelastegui; Pedro P España; Amaia Bilbao; Julio Gamazo; Federico Medel; Juan Salgado; Iñaki Gorostiaga; Maria Jose Lopez de Goicoechea; Inmaculada Gorordo; Cristobal Esteban; Lander Altube; Jose M Quintana
Journal:  BMC Infect Dis       Date:  2012-06-12       Impact factor: 3.090

9.  Community-acquired pneumonia: aetiologic changes in a limited geographic area. An 11-year prospective study.

Authors:  R Fernández Alvarez; I Suárez Toste; G Rubinos Cuadrado; A Torres Lana; J A Gullón Blanco; A Jiménez; I González Martín
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2007-07       Impact factor: 5.103

10.  Clinical characteristics of acute Q fever patients in South Korea and time from symptom onset to serologic diagnosis.

Authors:  Jung Yeon Heo; Young Wha Choi; Eun Jin Kim; Seung Hun Lee; Seung Kwan Lim; Seon Do Hwang; Ju Young Lee; Hye Won Jeong
Journal:  BMC Infect Dis       Date:  2019-10-28       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.